Discovery of a Novel B-Raf Fusion Protein Related to c-Met Drug Resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of a Novel B-Raf Fusion Protein Related to c-Met Drug Resistance

Published:2011-10-12 Issue:11 Volume:10 Page:5084-5094
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Dillon Roslyn¹,Nilsson Carol L.²,Shi Stone D.-H³,Lee Nathan V.⁴,Krastins Bryan⁵,Greig Michael J.⁴

Affiliation:

1. Sapphire Energy, San Diego, CA 92121, United States

2. University of Texas Medical Branch, Galveston, TX 77555, United States

3. Amgen, Inc., Thousand Oaks, CA 91320, United States

4. Pfizer Global Research and Development, La Jolla, California 92121, United States

5. Biomarker Research Initiatives in Mass Spectrometry (BRIMS), Thermo Fisher Scientific, Cambridge, Massachusetts 02139, United States

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr200498v

Reference58 articles.

1. Overexpression of theMET/HGF receptor in ovarian cancer

2. Overexpression of the met/HGF receptor in renal cell carcinomas

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphoproteomics changes due to allograft-induced stress responses of Pinctada fucata martensii;Comparative Biochemistry and Physiology Part D: Genomics and Proteomics;2024-03

2. WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway;The FASEB Journal;2021-01-21

3. Phosphoproteomic strategies in cancer research: a minireview;The Analyst;2020

4. Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies;Cell Metabolism;2018-12

5. Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation;Molecular Cancer Therapeutics;2016-09-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3